Copyright
©The Author(s) 2016.
World J Diabetes. Sep 15, 2016; 7(17): 354-395
Published online Sep 15, 2016. doi: 10.4239/wjd.v7.i17.354
Published online Sep 15, 2016. doi: 10.4239/wjd.v7.i17.354
Table 1 Classification of degree of obesity by body mass index
Body mass index (kg/m2) | |
Normal weight | 18.5-24.9 |
Overweight grade 1 | 25-26.9 |
Overweight grade 2 | 27-29.9 |
Obesity grade 1 | 30-34.9 |
Obesity grade 2 | 35-39.9 |
Obesity grade 3 (morbid) | 40-49.9 |
Obesity grade 4 (extreme) | ≥ 50 |
Table 2 Different formulas for calculating baseline energy needs of people
Harris-Benedict equation1 |
Males: BMR (kcal/d) = 66 + 13.7 × weight (kg) + 5 × height (cm) - 6.8 × age |
Females: BMR (kcal/d) = 655 + 9.6 × weight (kg) + 1.8 × height (cm) - 4.7 × age |
Mifflin St Jeor equation2 |
Males: BMR (kcal/d) = 10 × weight (kg) + 6.25 × height (cm) - 5 × age + 5 |
Females: BMR (kcal/d) = 10 × weight (kg) + 6.25 × height (cm) - 5 × age - 161 |
Table 3 Glycaemic index, glycaemic load and carbohydrates portion
GI: Observed increase in blood glucose after eating 50 g of a food, compared with the observed increase after intake of 50 g of white bread or glucose |
Glycaemic load: GI × total amount of carbohydrates (grams) of the usual food portion |
Carbohydrates portion: amount of food containing 10 g of carbohydrates |
Table 4 Relationship between maximum oxygen consumption, % of maximum heart rate and subjective perceived exertion
Intensity | % oxygen consumption | % maximum heart rate1 | Subjective perceived exertion |
Very light | < 20 | < 35 | < 10 |
Light | 20-39 | 35-54 | 10-11 |
Moderate | 40-59 | 55-69 | 12-13 |
High | 60-84 | 70-89 | 14-16 |
Very high | > 85 | > 90 | 17-19 |
Maximum | 100 | 100 | 20 |
Table 5 Type of insulin by onset of action, peak effect and duration of action
Insulin type | Onset of action | Peak effect | Duration of action |
Lispro, aspart, glulisine | 5 to 15 min | 45 to 75 min | 2 to 4 h |
Regular | About 30 min | 2 to 4 h | 5 to 8 h |
NPH | About 2 h | 4 to 12 h | 18 to 28 h |
Insulin glargine | About 2 h | No peak | 20 to 24 h |
Insulin detemir | About 2 h | No peak | 6 to 24 h1 |
NPL | About 2 h | Six hours | 15 h |
Insulin degludec | About 2 h | No peak | > 40 h |
Insulin U-300 | About 2 h | No peak | > 36 h |
- Citation: Marín-Peñalver JJ, Martín-Timón I, Sevillano-Collantes C, del Cañizo-Gómez FJ. Update on the treatment of type 2 diabetes mellitus. World J Diabetes 2016; 7(17): 354-395
- URL: https://www.wjgnet.com/1948-9358/full/v7/i17/354.htm
- DOI: https://dx.doi.org/10.4239/wjd.v7.i17.354